‘These viruses have the opportunity to wake up’: Severe COVID can reactivate other viruses lurking in the body, study suggestsAugust 24, 2026
Research BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nodBy Healthcare Propulsion StaffAugust 14, 20260 In a historic breakthrough for targeted protein degradation, Bristol Myers Squibb has secured the first FDA approval for a CELMoD…
